SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Microcide Pharmaceuticals (MCDE)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Czechsinthemail who wrote (67)5/30/1997 4:01:00 PM
From: Dave K   of 186
 
Something most people may not realize is that Microcide in conjunction with their partners reportedly have "the largest dedicated antibiotic research effort in the world". Even disputing that claim still places in them well in the fore-front of this critical research.

The latest AP story on bacterial resistance is only one of many that have surfaced in the last year. I would not be surprised to see accelerated research, approvals and more partnerships down the road.

Baird: What works best is to sell to institutions (mutual funds and the like) as the story grows. I've seen money sources lump venture capital firms in as institutional. These venture folks take the initial high risk and usually want the payback now so they can move on something in conception. This volatility should change as the shares move into stronger investor hands. Just a thought.

Dave
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext